The focus of Dr. Garrett’s research program is host-microbiota interactions in health and disease. Her laboratory studies the interplay between the gastrointestinal immune system and the gut microbiota in health, inflammatory bowel disease (IBD) and colorectal cancer (CRC).
Dr. Huttenhower performs research at the intersection of microbial community function and human health, including computational methods development and microbiome population studies to characterize molecular mechanisms in chronic disease.
Dr. Chan’s work currently focuses on chronic digestive diseases, including gastrointestinal cancer (colorectal, esophageal, pancreatic), inflammatory bowel disease, diverticulitis, and gastrointestinal bleeding.
Dr. Rimm’s research group has specific interests both in the study of modifiable lifestyle choices (e.g. diet and physical activity) in relation to cardiovascular disease as well as the translation of these findings into public health interventions that are effective for schoolchildren, adults and the food insecure.
Dr. Wirth’s research investigates protozoan parasites, which remain major causes of disease in developing countries throughout the world, while little is known about the biology or molecular biology of these organisms. The group’s long term goal is to understand basic molecular mechanisms in protozoan parasites with the aim of discovering and applying parasite-specific interventions.
Dr. Hu’s research has focused on diet/lifestyle, metabolic, and genetic determinants of obesity, type 2 diabetes, and cardiovascular disease (CVD). This includes the epidemiology and prevention of cardio-metabolic diseases through diet and lifestyle, gene-environment interactions and risk of obesity and type 2 diabetes, nutritional metabolomics in type 2 diabetes and cardiovascular disease, and obesity, metabolic phenotypes, and cardiovascular disease in Chinese populations.
